Dr Reddy’s Eyes Generic Revlimid Exclusivity With ANDA Approval

Follows Natco ANDA Approval Earlier This Year; Market To Form In Months

Firms Await Regulatory Inspections
BMS anticipates 'more of a slope than a cliff' • Source: Alamy

More from Generics

More from Products